The Valley Desk

NCT02091245 · Interventional trial

Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML

Overall registry status Active not recruiting

Phase 1

Conditions Chronic Myelogenous Leukemia (CML) in Blast Crisis, Refractory Acute Lymphoblastic Leukemia (ALL), Refractory Acute Myelogenous Leukemia (AML), Refractory Biphenotypic Leukemia, Refractory Mixed Lineage Leukemia, Relapsed Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML), Relapsed Biphenotypic Leukemia, Relapsed Mixed Lineage Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov